Developed skills and lines of research
Cesare Braggion earned his degree in Medicine and Surgery in 1979 from the University of Bologna and specialized in Pediatrics in 1983 at the University of Verona. Until 2018, he was the head of the Cystic Fibrosis Unit within the Department of Integrated Activities in Internal Pediatric Care at the Meyer University Hospital in Florence. Since 2019, he has been a member of the Board of Directors of the Italian Cystic Fibrosis Research Foundation (FFC Ricerca).
Since November 2007, he has coordinated the Editorial and Website Committee of the Italian Society for the Study of Cystic Fibrosis (SIFC). He is also a lecturer in Pulmonology at the Pediatric Specialization School of the University of Florence, an instructor for the Pediatric Physiotherapy Master’s Program at the University of Florence’s Department of Pediatrics, and a member of the Organizing Committee for the Cystic Fibrosis Master’s Program in the same department.
He has been active in clinical research on childhood respiratory diseases and cystic fibrosis for many years, with a particular focus on respiratory pathophysiology and respiratory therapy/rehabilitation. Since 2021, he has been part of the Scientific Directorate of the Italian Cystic Fibrosis Research Foundation (FFC Ricerca), overseeing and promoting clinical research activities.
Projects funded by FFC Ricerca as Principal Investigator or as Research Manager
FFC Research strategic project 2021-2023. Kaftrio effect in advanced disease.
Efficacy and safety study of Kaftrio in real life in people with advanced CF
FFC#25/2015
Are CF guidelines credible? Evaluating methodological issues
FFC#16/2007
Control and prevention of respiratory infections in Cystic Fibrosis patients: an evaluation of the emission distance of Pseudomonas aeruginosa from the respiratory tract of infected persons through coughing and conversation
FFC Research strategic project 2023-2025. Kaftrio in real life. Kaftrio in real life Effectiveness and safety of Kaftrio in real life: Italian observational and multicenter study
Projects financed by FFC Ricerca as a partner
FFC#23/2009
Modulation of intestinal and extraintestinal inflammation in infants with cystic fibrosis by early modification of intestinal microflora
FFC#16/2008
A prospective study about complications of totally implantable central venous access ports in people with CF
Publications from FFC Research projects
Dal Molin A, Gatta C, Festini F., Management of totally implantable vascular access devices in patients with cystic fibrosis. Minerva Pediatr, 2009, 61(5):549-55
Festini F, Taccetti G, Galici V, et al., A 1-m distance is not safe for children with cystic fibrosis at risk for cross-infection with Pseudomonas aeruginosa. Am J Infect Control, 2010, 38(3):244-5
Dal Molin A, Di Massimo DS, Braggion C et al., Totally implantable central venous acces ports in patients with cystic fibrosis: a multicenter prospective cohort study. J Vasc Access, 2012, 13(3):290-5
Bruzzese E, Callegari ML, Raia V et el., Disrupted intestinal microbiota and intestinal inflammation in children with cystic fibrosis and its restoration with Lactobacillus GG: a randomised clinical trial. PLoS ONE, 2014, 9(2):e87796